Canada markets closed

Synvista Therapeutics, Inc. (SYNI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 03:28PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 35.21
52-Week Change 3-99.00%
S&P500 52-Week Change 322.36%
52 Week High 30.0001
52 Week Low 30.0000
50-Day Moving Average 30.0001
200-Day Moving Average 30.0001

Share Statistics

Avg Vol (3 month) 3352
Avg Vol (10 day) 3367
Shares Outstanding 52.59M
Implied Shares Outstanding 6N/A
Float 8N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 20.02:1
Last Split Date 3Jul 25, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2007
Most Recent Quarter (mrq)Sept 30, 2008

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-379,312.06%

Management Effectiveness

Return on Assets (ttm)-50.59%
Return on Equity (ttm)-102.91%

Income Statement

Revenue (ttm)54.73k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-27.60%
Gross Profit (ttm)N/A
EBITDA -11.01M
Net Income Avi to Common (ttm)-19.8M
Diluted EPS (ttm)-7.6570
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.96M
Total Cash Per Share (mrq)3.08
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.01
Book Value Per Share (mrq)1.73

Cash Flow Statement

Operating Cash Flow (ttm)-9.32M
Levered Free Cash Flow (ttm)-3.78M